coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Banstead Healthcare PCN, Reigate and Banstead · Health Inequalities Profile

    PCN U42235 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    48,269

    Registered population

    55.7% aged 18–64

    24.8%

    Aged 65+

    ICB 18.8% · England 17.9%

    14.1%

    Ethnic minority (non-White)

    7.2% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    8,252

    Hypertension register

    +2.94% in 3 yrs · England +5.60%

    375

    SMI register

    32.6% of Reigate and Banstead's

    743

    COPD register

    Reviews +5.45% in 3 yrs

    Forecast to 2030

    8,947

    Hypertension patients, 2030

    +695 on today

    59.4%

    QRISK ≥20% on statins, 2030

    +0.46pp over 3 yrs

    7.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    57.1%
    Asthma annual reviews trail England and ICB.

    Only 57.1% of asthma patients had an annual review (England 65.7%, ICB 65.6%), leaving about 1,200 of 2,843 registered patients unreviewed.

    58.5%
    High-risk lipid therapy lags national rates.

    Lipid therapy for QRISK ≥ 20% is 58.5% (England 63.6%, 3-year change +0.8% vs +6.2%) and 63.7% in CKD (England 70.3%).

    73.6%
    Overall hypertension and diabetes control exceed England.

    Hypertension treatment to threshold is 73.6% (England 70.3%) and non-frail diabetes HbA1c control is 64.4% (England 57.4%), though 80+ BP control trails at 77.9%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    With 24.8% aged 65+, an older population structure shapes primary care demand

    Across 48,269 registered patients, 24.8% (11,986) are aged 65+, above Reigate and Banstead (19.4%), NHS Surrey Heartlands ICB (18.8%) and England (17.9%). Working-age adults (18–64) make up 55.7% (26,899), below the borough (59.6%), ICB (60.8%) and England (62.7%), with 19.4% (9,384) aged 0–17. Census estimates show an 85.9% White population (borough 84.4%, ICB 85.3%, England 81.1%) and a 14.1% ethnic minority share, with Asian residents at 7.2% (England 9.6%). Projected list growth to 2030 is 1.9% (unverified methodology). Ethnicity reflects Census usual residents, not registered patients.

    Age profile

    0–1719.4%
    18–6455.7%
    65+24.8%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White85.9%
    Asian7.2%
    Mixed3.4%
    Black2.0%
    Other1.4%

    Older people · falls rows are Reigate and Banstead local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Reigate and Banstead LA)2,1542,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)87.6%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)64.4%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Reigate and Banstead LA)9919819552024/25
    Falls deaths, all ages, per 100,000 (Reigate and Banstead LA)8.914.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 8.7 and all five practices record 0.0% Core20

    Banstead Healthcare PCN has an average IMD decile of 8.7, against 8.0 in Reigate and Banstead, 7.9 in the ICB and 5.5 in England. Across all five practices, 0.0% of registered patients live in Core20 deciles 1 and 2, against 1.1% in the borough, 0.8% in the ICB and 21.0% in England. Practice IMD deciles range from 8.1 at Tadworth Medical Centre to 9.1 at Longcroft Clinic. With zero Core20 patients, health inequality work could focus on clinical inclusion groups rather than neighbourhood outreach.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Nork Clinic0.0% · 0 patients
    Heathcote0.0% · 0 patients
    Longcroft Clinic0.0% · 0 patients
    Tadworth0.0% · 0 patients
    Tattenham0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    375

    SMI register

    0.77% recorded prevalence

    229

    Learning disability register

    0.47% recorded prevalence

    33

    Care homes, 1,286 beds

    In the PCN catchment

    7.9%

    Provide unpaid care

    Reigate and Banstead, Census 2021

    The PCN records 229 patients on the learning disability register (0.5% vs borough 0.6%, England 0.6%) and 375 on the severe mental illness register (0.8% vs England 1.0%), alongside 33 catchment care homes (1,286 beds; occupancy unmeasured). Lower crude recorded prevalence does not establish under-detection; clinical audits would test whether identification gaps exist.

    Severe mental illness: physical health checks

    Recorded SMI checks reach 89.4% for BP (England 83.4%) and 87.9% for BMI (England 82.1%). However, BMI recording fell 2.4 pp over three years (England +5.1 pp), pointing to emerging gaps in routine physical health monitoring.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,252

    Hypertension register

    +2.94%

    Register growth, 3 yrs

    Reigate and Banstead +4.55% · England +5.60%

    +1.66pp

    BP control, under 80

    ≤140/90 · −1.36pp aged 80+

    +695

    More patients by 2030

    Forecast 8,947 (18.00%)

    Hypertension case-finding and control

    Banstead Healthcare PCN records hypertension prevalence of 17.0% (8,252 patients), above Reigate and Banstead (14.0%), NHS Surrey Heartlands Integrated Care Board (14.3%) and England (15.2%). Blood pressure control under age 80 is 71.8% (England 67.8%), but control in patients aged 80 and over trails at 77.9% versus England's 81.2%, falling 1.7% over three years (England +2.2%). Hypertension blood pressure recording reached 88.2% (England 90.0%). Lower control in patients aged 80 and over than national benchmarks warrants prioritising clinical review and medication titration for older hypertensive cohorts.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy uptake is 58.5%, trailing Reigate and Banstead (59.3%), NHS Surrey Heartlands Integrated Care Board (59.4%) and England (63.6%). CKD lipid therapy uptake is 63.7% (England 70.3%). Fewer at-risk cardiovascular patients receive lipid-lowering therapy than England rates imply, prioritising a systematic recall audit for high-risk cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202666,853£2.20£2.24£1.86£147,077
    Cardiovascular (all), 202593,909£4.54£4.74£3.33£426,347

    In 2025, lipid-modifying drug spend was £121,877 across 55,907 items at £2.18 per item, matching NHS Surrey Heartlands Integrated Care Board (£2.18) but above Reigate and Banstead (£2.11) and England (£1.82), costing £20,127 more than at England's unit cost. Higher unit costs than England suggest reviewing lipid-modifying prescribing choices alongside local formulary guidance to balance spend and treatment reach.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +3.43%

    Asthma reviews, PCN 3-yr change

    +4.44%

    Asthma reviews, England

    +6.17%

    Asthma prevalence, PCN

    Asthma prevalence is 6.2% (England 6.6%), with three-year register growth of +6.2% (England +0.5%). However, only 57.1% of asthma patients received an annual review, trailing the borough (59.8%), ICB (65.6%) and England (65.7%), leaving an estimated shortfall of about 1,200 of 2,843 patients unreviewed. Second-hand smoke status recording for ages 6–19 also lags at 74.5% (England 78.8%). Conversely, COPD reviews reach 82.2% (England 76.4%), suggesting review recall systems exist but leave a substantial unreviewed asthma cohort.

    Cancer register and children's immunisation

    Cancer prevalence is 5.5% (2,696 patients), exceeding England (3.8%), consistent with the PCN's older demographic. In childhood immunisation, 6-in-1 uptake reaches 97.9% at 12 months, exceeding the 95.0% target. However, in separate age 5 cohorts, MMR dose 2 is 87.5% and the 4-in-1 booster is 85.7%, both trailing the 95.0% benchmark. This suggests pre-school booster recall requires structured follow-up across primary care.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.9%

    England 91.0%

    6-in-1 complete primary course at 24 months90.7%

    England 92.2%

    MMR dose 1 at 24 months89.7%

    England 88.3%

    MMR dose 2 at age 587.5%

    England 82.8%

    4-in-1 pre-school booster at age 585.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In 2022, 61.4% of staged cancers in NHS Surrey Heartlands ICB were diagnosed at stage 1 or 2 (2,955 of 4,810), exceeding England (55.3%) by 6.1 percentage points but sitting 13.6 pp below the 75.0% national ambition by 2028. Known-stage share was 67.7% (4,810 of 7,106 registered cancers). Bowel was 48.1% (26.9 pp below ambition) and lung 33.2% (41.8 pp below ambition). Reaching 75.0% requires about 650 (652.5) extra early-stage diagnoses annually across the ICB (system data, not PCN level). Cervical screening reached 73.3% across the PCN (England 66.8%), spanning 68.0% at Heathcote Medical Centre to 70.8% at Tadworth Medical Centre.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Epsom and St Helier University Hospitals NHS Trust met all three cancer waiting standards: 62-day referral to treatment at 86.8% (standard 85.0%), 28-day faster diagnosis at 89.7% (standard 75.0%) and 31-day combined treatment at 99.2% (standard 96.0%). Conversely, NHS Surrey and Sussex Integrated Care Board achieved 71.5% on 62-day waits (13.5 pp below standard; England 71.2%), Surrey and Sussex Healthcare NHS Trust reached 70.0% and Croydon Health Services NHS Trust 69.9%. Diagnostic six-week waits at Epsom and St Helier were 1.1% for CT and 0.3% for MRI.

    Pathways within standard (%)Epsom and St HelierSurrey and Sussex HealthcareCroydon HealthSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)89.7077.7483.2279.2979.32
    31-day treatment (96%)99.1696.2099.0690.4592.50
    62-day referral to treatment (85%)86.8269.9769.8871.5171.16
    Diagnostic waits over 6 weeks (%)Epsom and St HelierSurrey and Sussex HealthcareCroydon HealthEngland
    MRI0.3127.530.2621.40
    CT1.0618.497.699.92
    Echocardiography25.4943.783.6028.48
    Colonoscopy33.0115.1121.8030.83
    Gastroscopy30.9021.0617.9429.02
    All 15 DM01 tests6.8328.503.5123.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In Jun 2026 (provisional), adults aged 65 and over accounted for 69.6% of community service contacts among Reigate and Banstead residents (76,215 of 109,530 contacts). This pattern is consistent with the area's older demographic profile. These figures reflect local authority resident contacts rather than registered patients, describing wider system demand rather than Banstead Healthcare PCN delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access and vaccination achievement vary widely across the five member practices

    In 2025/26, clinical-domain QOF achievement spanned 97.0% at Heathcote Medical Centre to 100.0% at Longcroft Clinic (England 97.1%). Conversely, vaccination and immunisation achievement diverged by 56.0 pp, from 27.6% at Tadworth Medical Centre to 83.5% at Tattenham Health Centre (England 55.2%), demonstrating internal variation across member practices.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Tattenham1120.070.1%62.5%91.6%
    Longcroft Clinic1150.053.0%78.2%83.6%
    Tadworth860.043.6%79.6%78.6%
    Heathcote1040.040.0%65.1%78.3%
    Nork Clinic1140.053.5%69.8%76.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNReigate and BansteadAssetPCNReigate and Banstead
    Care homes (catchment)33 (1,286 beds)n/aSchools (catchment)44n/a
    Children's centres28Places of worship2670
    Libraries26Food banks (VCS)n/a6
    Homelessness support (VCS)n/a2Day centres (VCS)1440
    Children and young people (VCS)n/a8Carers support groups (VCS)16
    Primary schools (LA maintained)514Primary academies818

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma annual review coverage is 57.1% across 2,843 registered patients, compared with Reigate and Banstead (59.8%, difference -2.7 percentage points), NHS Surrey Heartlands Integrated Care Board (65.6%, difference -8.5 percentage points) and England (65.7%, difference -8.6 percentage points), leaving about 1,200 (1,220) patients without a recorded review in the last. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Learning disability register coding audit

    Recorded learning disability prevalence is 0.5% (229 patients across a 48,269 list), below Reigate and Banstead (0.6%) and England (0.6%) by 0.1 percentage points (benchmark scenario range +55 to +57). For discussion: practices could audit clinical records for uncoded learning disability diagnoses and cross-check lists where social-care data sharing exists. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Option 3

    Heart failure register and review audit

    Heart failure prevalence is 0.9% (445 patients across 48,269 registered) versus England's 1.1% (borough 0.8%; range -61 to +85), while annual reviews fell 3.8% over three years (England +8.7%). For discussion: practices could audit heart failure coding and recall processes so functional capacity assessments are recorded at annual review. Low cost, quick to run.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Age-standardised register audit (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Annual mental health physical checks (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Older hypertension clinical review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted screening uptake review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephone triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD patients with a review in the last 12 monthsCore20PLUS5 respiratoryPCN
    Option 2 · Learning disability register coding audit (p12)Registered population · Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Option 3 · Heart failure register and review audit (p12)Registered population · Heart failure register · Heart Failure: QOF prevalence—PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15